List of leading stocks of biosafety concept
1, Bio-Co., Ltd. (60020 1), March 2, 2020 Interactive Platform Reply: The P3 laboratory of the company will adopt a platform operation mode, which not only meets the needs of the company's own R&D projects, but also faces the market-oriented in vitro high-quality R&D projects and team joint research and development. At present, P3 Laboratory has completed the R&D project and related resource allocation, and recently conducted many experiments in the procurement and transportation of consumables.
2. Haier Bio (688 139), the domestic leader in biomedical cryogenic storage, ranks first in product market share; Mainly engaged in research and development, production and sales of biomedical cryogenic storage equipment *; The company independently develops and produces basic laboratory instruments and equipment such as biosafety cabinets, clean workbench carbon dioxide incubators and so on.
3. Zaisheng Technology (60360 1). Suzhou Youyuan, a wholly-owned subsidiary of the company, has strong competitiveness in biosafety protection. Participated in P3 large-scale animal house project in Shen Lian Biological Phase II and P3 workshop project of inactivated H7N9 avian influenza vaccine in Dahuanong successively.
4. Shensangda A(000032). At present, China has undertaken workshop projects of Beijing Institute of Biological Products, Wuhan Institute of Biological Products, Beijing Kexing Biological Products Co., Ltd., Kangxinuo Biological Co., Ltd. and many other companies. The vaccine workshop project of Beijing Institute of Biological Products is the first P3 biomedical workshop project for human use in China. The implementation of the above projects will provide technical support and industry reputation for China system to undertake similar projects in the future.
5. China Zhongyuan's China Engineering Corporation (00205 1) has a business chain integrating medical treatment, consulting and planning for the elderly, architectural design for the elderly, cleaning, biological safety experiments, general contracting of projects and complete sets of engineering medical equipment.
6. Chutian Technology (300358), a wholly-owned subsidiary of Sichuan Medical Design Institute, has the design and construction capability of P3 biosafety laboratory; During the COVID-19 epidemic, Sichuan Medical Design Institute undertook the design of the high-grade biosafety laboratory of Guangzhou Eighth People's Hospital.
7. Xinhua Pharmaceutical (000756). On May 27th, 2020, the company said on the interactive platform that its subsidiary, Shandong Xinhua Pharmaceutical Co., Ltd., had P2 and P3 laboratory design qualifications.
8. Hejia Medical (300273). On May 26th, 2020, the company indicated on the interactive platform that it had relevant qualifications and could build P2 and P3 laboratories.
9. Shang Rong Medical (00255 1), May 27, 2020 Interactive Platform Reply: At present, the company has a professional team engaged in the design and construction of P3 and below laboratories, and some products of the company can be used in P2/P3 laboratories.
10, Xinlun Technology (00234 1), a wholly-owned subsidiary of Shanghai Hanguang, is a member of SEFA and has the ability to design and implement P2 and P3 laboratories.
1 1, Chuangyuan Technology (00055 1), a holding subsidiary of Jiangsu Su Jing Jidu Co., Ltd., produces the highest level 3 biosafety cabinet (corresponding to P4 laboratory), which has been used in Ebola virus research in Central Africa.
12, Lv Chang co., ltd. (002 160), a subsidiary of longmai medical cleaning co., ltd., can undertake the business of cleaning laboratories, and Sichuan longmai, a subsidiary of longmai, has been expanding its cleaning engineering business to hospitals.
13, Yihua Health (000 150) and Shenzhen Zhongankang Medical Project (holding 85% of the shares) held by Zhongankang Logistics Group, a wholly-owned subsidiary of the company, have the professional construction qualification of purification engineering and the ability to undertake P3 laboratory project project.
14, Yimikang (300249), May 27, 2020 Interactive Platform Reply: Sanruisi, a wholly-owned subsidiary of the company, has the technology and experience in the construction of biological laboratories.
15, Tailin Bio (3008 13), the company's main business is microbial detection and control technology system products, organic matter, analytical instruments and other pharmaceutical equipment. Specific products include all kinds of consumables, instruments and equipment that can be used in the production and quality inspection of sterile drugs alone or in combination.